
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
San Francisco - Supplemental patch testing for allergens not included in TRUE Test is necessary, albeit less convenient, for dermatologists, according to Erin M. Warshaw, M.D.






